1.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 21 at diagnosis
Sponsor: NCI
Protocol IDs: POG-9406, POG-ALINC-16/HR
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: at least 1 + under 20 at diag.
Sponsor: NCI
Protocol IDs: CCG-1941
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 9
Sponsor: NCI
Protocol IDs: CCG-1952, NCT00002744
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MSKCC-96015A1, NCI-V96-0881, NCT00002766
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: CCG-1961, NCT00002812
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-1951, NCT00002816
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 18
Sponsor: Other
Protocol IDs: MRC-LEUK-ALL97, EU-97032, NCT00003437
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 9
Sponsor: NCI
Protocol IDs: COG-P9904, POG-9904, NCT00005585
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21 at diagnosis
Sponsor: NCI
Protocol IDs: COG-P9905, POG-9905, NCT00005596
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 9
Sponsor: NCI
Protocol IDs: COG-C1991, CCG-1991, NCT00005945
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: COG-AALL0031, NCT00022737, AALL0031
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 12 months to 21 years
Sponsor: NCI
Protocol IDs: POG-9006
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: DFCI-91001, NCI-T91-0059D, T91-0059
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 22
Sponsor: NCI
Protocol IDs: POG-9295
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 21 years
Sponsor: NCI
Protocol IDs: POG-9202
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 12 months to 21 years
Sponsor: NCI
Protocol IDs: POG-9203
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to under 31
Sponsor: NCI
Protocol IDs: COG-AALL0232, NCT00075725, AALL0232
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to under 10
Sponsor: NCI
Protocol IDs: COG-AALL0331, AALL0331, NCT00103285
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 17
Sponsor: NCI, Other
Protocol IDs: 05-001 / CDR0000513019, P01CA068484, P30CA006516, DFCI-05001, NCT00400946
|
|
20.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: ID03-0124, NCT00452439
|
|
21.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 1 to 30
Sponsor: NCI
Protocol IDs: NCI-2009-00312, AALL0622, CDR0000600217, U01CA98543, COG-AALL0622, NCT00720109
|
|
22.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: over 1 to 21
Sponsor: NCI
Protocol IDs: POG-9061
|
|
23.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: under 30
Sponsor: NCI
Protocol IDs: ENZON-ASP-305, NCI-91-C-116, NCI-T91-0129N, T91-0129
|
|
24.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: ENZON-ASP-107, NCI-V93-0255
|
|
25.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Over 1 and under 21
Sponsor: Other
Protocol IDs: T2005-003, NCT00440726
|
Mobile | Español
